Search Results
Sep 20, 2026, 22:00 ET Solidion Technology Board Appoints Jaymes Winters as Chairman and CEO; Mark Schwartz as Lead Independent Director
to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law.Please follow us on:LinkedIn:
More news about: Solidion Technology, Inc.
Sep 20, 2026, 22:00 ET 아시아•태평양 대표 뷰티 행사 코스모프로프 아시아 2026, 사전 기자간담회에서 미리 공개
행사로서의 입지를 지속적으로 강화해 나가겠다는 비전을 재확인했다. 향수는 아시아•태평양 지역에서 해당 카테고리가 성장하고 있는 점을 반영해 여전히 전략적 중점 분야로 자리하고 있다. 엑상스(Esxence)와의 파트너십도 새롭게 이어져 익스플로러 바이 엑상스(Explorer by Esxence)를 통해 아시아 향수 브랜드와 국제 니치 향수 업계를 연결한다.주최 측은 "코스모프로프 아시아는 비교할 수 없는 비즈니스 기회를 제공하는, 놓쳐서는 안 될 국제 뷰티 무역 행사"라며 "전시업체와 공급망 리더, 바이어를 연결함으로써 글로벌 뷰티
More news about: Cosmoprof Asia
Sep 20, 2026, 21:54 ET Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
2025[2]. This commercial momentum is underpinned by increasing global demand for TRT and radioisotopes for commercially approved products and assets under clinical development. The global nuclear medicine market is forecast to reach US$41 billion by 2034[3].ITM's late-stage novel pipeline
More news about: Telix Pharmaceuticals Limited
Sep 20, 2026, 21:53 ET MetaOptics Secures up to US$10 Million Investment Facility from White Lion Capital, Its First U.S. Institutional Investor, to Onshore Metalens Technology into the U.S.
adoption, driven by consumer electronics, AR/VR wearables, automotive sensing and the multi-billion dollar CPO industry serving AI data centres. MetaOptics is currently working with several U.S. foundries to integrate its metalenses into their CPO designs. The smallest CPO metalens designed by MetaOptics measures
More news about: MetaOptics Ltd
Sep 20, 2026, 21:00 ET Abbisko Therapeutics Announces Positive Preliminary Phase 2 Results with Lavengratinib (ABSK061) for the Treatment of Achondroplasia
gained regulatory approval globally. However, the therapeutic window of pan-FGFRs and their clinical efficacy have been limited by side effects associated with FGFR1 inhibition. By reducing FGFR1 activity while maintaining potency against FGFR2 and FGFR3, lavengratinib is expected to achieve a wider therapeutic
More news about: Abbisko
Sep 20, 2026, 21:00 ET Convera and JustLogin Partner to Enable Cross-Border Payroll and Payments Across Singapore and Southeast Asia
managing distributed workforces across the region."Growing companies should not have to choose between regional expansion and payroll confidence. By embedding Convera's global payments capabilities directly into JustLogin's HR platform, we're making it easier for businesses to hire, pay and scale
More news about: Convera
Sep 20, 2026, 21:00 ET LG Display launches 24.5-inch 720Hz Gaming OLED Panel
for esports.Standard monitors used for esports are primarily in the 24-inch class, enabling players to view the entire screen at a glance.By initiating mass production of its 24.5-inch 720Hz Gaming OLED panel, LG Display aims to pioneer the mainstreaming of OLED technology across the esports
More news about: LG Display
Sep 20, 2026, 20:57 ET UN Private Sector Forum calls for faster public-private action to deliver a clean, just and secure energy future
Hosted by the UN Global Compact on behalf of UN Secretary-General António Guterres, the invitation-only Forum brought together more than 100 Chief Executive Officers,
More news about: United Nations Global Compact
Sep 20, 2026, 20:30 ET Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022
ATG-022 was previously granted Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA). This designation has facilitated efficient regulatory
More news about: Antengene Corporation Limited
Sep 20, 2026, 20:05 ET Velocys expands Fischer-Tropsch reactor roadmap with AlphaCore 800 for larger-scale SAF and e-fuels projects
requiring approximately 1,600 barrels per day (60 kt/a) of FT liquids could be configured with two AlphaCore 800 reactors. This reduces total reactor count by 75% compared to an FT unit utilizing eight AlphaCore 200 reactors while maintaining the same FT liquids capacity."Customers are asking us to bring
More news about: Velocys
Sep 20, 2026, 20:05 ET Velocys expands Fischer-Tropsch reactor roadmap with AlphaCore 800 for larger-scale SAF and e-fuels projects
requiring approximately 1,600 barrels per day (60 kt/a) of FT liquids could be configured with two AlphaCore 800 reactors. This reduces total reactor count by 75% compared to an FT unit utilizing eight AlphaCore 200 reactors while maintaining the same FT liquids capacity."Customers are asking us to bring
More news about: Velocys
Sep 20, 2026, 20:00 ET 01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
fintech sector and reflects its conviction that Indonesia remains one of the region's most dynamic digital-payments markets, underpinned by high digital adoption, a large consumer base and growing demand for technology-enabled financial services.
More news about: 01F Group
Sep 20, 2026, 19:30 ET The Walter Family Reaffirms Longstanding Philanthropic Commitment and Forcefully Rejects False and Defamatory Claims
behind the causes and institutions that have defined their philanthropic work for decades. The Walters' philanthropy has also been strengthened by longtime partners who share the same conviction and commitment. "Liz and I have worked alongside Mark and Kimbra Walter in several of these
More news about: The Walter Family
Sep 20, 2026, 19:21 ET Bloom Energy Deadline: BE Investors Have Opportunity to Lead Bloom Energy Corporation Securities Fraud Lawsuit
alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.Details of the case: According to the lawsuit, throughout the Class Period,
More news about: THE ROSEN LAW FIRM, P. A.
Sep 20, 2026, 19:01 ET GDDY Deadline: GDDY Investors Have Opportunity to Lead GoDaddy Inc. Securities Fraud Lawsuit
alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.Details of the case: According to the lawsuit, throughout the Class Period,
More news about: THE ROSEN LAW FIRM, P. A.
Sep 20, 2026, 17:44 ET HDC Deadline: HDB Investors Have Opportunity to Lead HDFC Bank Limited Securities Fraud Lawsuit
alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.Details of the case: According to the lawsuit, defendants made materially
More news about: THE ROSEN LAW FIRM, P. A.
Sep 20, 2026, 17:00 ET Monster Energy's Joshua Van Defeats Alexandre Pantoja to Retain UFC Flyweight Championship Title at UFC 331 in Los Angeles
bell.When the judges went to their scorecards, defending champion Van prevailed by shutting down his opponent's grappling and landing 259 significant strikes in a relentless battle between unyielding opponents. As the winner by unanimous decision (50-45, 49-46, 49-47), Van secured his second title defense
More news about: Monster Energy
Sep 20, 2026, 17:00 ET SparkLabs and Mirae Asset Launch a Venture Capital Fund for Central Asian Startups
Asset Venture Investment and SparkLabs Group have signed a term sheet to establish SparkLabs Mirae Silk Road Fund I LP, a new venture capital fund. The fund will be managed by Mirae Asset Venture Investment and SparkLabs Group.
More news about: SparkLabs Group
Sep 20, 2026, 16:29 ET Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.Follow us for updates on LinkedIn:
More news about: THE ROSEN LAW FIRM, P. A.
Sep 20, 2026, 16:15 ET EQPT Deadline: EQPT Investors Have Opportunity to Lead EquipmentShare.com Inc Securities Lawsuit
alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.Details of the case: According to the lawsuit, in the Registration Statement
More news about: THE ROSEN LAW FIRM, P. A.
Sep 20, 2026, 16:15 ET AECOM Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Hackers Allege Theft of More Than 1 TB of Data
increasing the risk of identity theft and fraud. Affected individuals should treat any AECOM breach notification seriously.Who May Be Affected by the AECOM Data BreachThe investigation focuses on current and former AECOM employees, clients, and anyone else whose personal information
More news about: Edelson Lechtzin LLP
Sep 20, 2026, 16:02 ET CCOI Deadline: CCOI Investors Have Opportunity to Lead Cogent Communications Holdings, Inc. Securities Fraud Lawsuit
alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.Details of the case: According to the lawsuit, defendants throughout
More news about: THE ROSEN LAW FIRM, P. A.
Sep 20, 2026, 16:00 ET Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia
Singapore, ST partners with global pharmaceutical, biotech and diagnostic companies to bring novel healthcare opportunities to patients who are impacted by a range of diseases. ST has built a strong track record of success, navigating complex regulatory, reimbursement and commercialisation environments in
More news about: Specialised Therapeutics
Sep 20, 2026, 15:41 ET JACC: Clinical Electrophysiology誌、Field Medicalによる初のヒト対象Field PULSE試験の12か月成績を掲載：最適化波形で静脈単位のPVI持続率94.2％
『瞬時』ポイント・バイ・ポイント・アブレーションのための高電圧フォーカルPFAカテーテル：AF治療を目的とした初のヒト対象FIELD-PULSE試験（High-Voltage Focal PFA Catheter for 'Instant' Point-By-Point Ablation: The First-In-Human FIELD-PULSE Trial to Treat AF）」と題する研究が、『JACC: Clinical Electrophysiology』オンライン版に、HRXでの発表と同時に掲載されました。DOI:
More news about: Field Medical, Inc.
Sep 20, 2026, 15:37 ET JACC: Clinical Electrophysiology veröffentlicht die 12-Monats-Ergebnisse der ersten Field PULSE-Studie am Menschen von Field Medical: 94,2 % PVI-Haltbarkeit pro Vene bei optimierter Wellenform
High Voltage Focal PFA Catheter for 'Instant' Point-By-Point Ablation: The First-In-Human FIELD-PULSE Trial to Treat AF" wurde online in der Fachzeitschrift JACC: Clinical Electrophysiology parallel
More news about: Field Medical, Inc.